Monitoring and responding to adverse events following immunization (AEFIs)

This module outlines the minimal approaches that countries should have in place for detecting, handling and responding to adverse events following COVID-19 immunization (AEFIs) and also the additional approaches that countries with more resources can undertake. It describes the practical differences for establishing COVID-19 vaccine safety surveillance system based on the types of vaccine platforms, different population profiles, handling high number of AEFI reports and the need to anticipate new events not previously seen during vaccine clinical trials.

#  

Module material 

Training material